Robert Califf, MD, most recently head of the US Food and Drug Administration, is joining Verily Life Sciences in an advisory role and will sit on the company’s scientific board. The news came just days after Verily announced the departure of former National Institute of Mental Health chief Thomas Insel, MD, from its team.
Verily is a subsidiary of Google parent company Alphabet. In a recent blog post, Califf said his key motivation for accepting the job was “to find ways to combine Silicon Valley’s technical prowess with expertise in the practical application of technologies in health and healthcare for the nation’s benefit.” Califf said he will also hold positions at the Duke Clinical Research Institute and the Stanford University Department of Medicine.
Abbasi J. Ex-FDA Chief Robert Califf, MD, Heads to Silicon Valley. JAMA. 2017;318(2):116. doi:10.1001/jama.2017.8765